Swallowing News and Research

RSS

Hypnosis has potential therapeutic value in children with respiratory disorders

Hypnosis has potential therapeutic value in children with respiratory disorders for alleviating symptoms such as habit cough or unexplained sensations of difficulty breathing and for lessening a child's discomfort during medical procedures.

15 Feb 2010

New review highlights risks and benefits of fluoride toothpaste in young children

Everyone who has ever seen a toothpaste commercial knows that fluoride is the ingredient that helps fight tooth decay, but a new review has determined exactly how much fluoride is best in toothpastes for children.

21 Jan 2010

Parents advised to use fluoridated toothpaste to prevent tooth decay in their children

Parents should use toothpastes that contain fluoride with a minimum concentration of 1,000 parts per million to prevent tooth decay in their children, says a new report. Preventing tooth decay can help reduce the need for extensive and costly dental treatments, including extractions.

20 Jan 2010

Organization of the brain's dictionary

Two hundred years ago, archaeologists used the Rosetta Stone to understand the ancient Egyptian hieroglyphs. Now, a team of Carnegie Mellon University scientists has discovered the beginnings of a neural Rosetta Stone. By combining brain imaging and machine learning techniques, neuroscientists Marcel Just and Vladimir Cherkassky and computer scientists Tom Mitchell and Sandesh Aryal determined how the brain arranges noun representations. Understanding how the brain codes nouns is important for treating psychiatric and neurological illnesses.

18 Jan 2010

BDSI to discuss planned BEMA Granisetron IND with the FDA

BioDelivery Sciences International, Inc. announced that the company has been granted a meeting with the U.S. Food and Drug Administration (FDA) to discuss the planned Investigational New Drug (IND) application for BDSI’s antiemetic (anti-nausea and vomiting) product candidate, BEMA Granisetron. The meeting will take place on March 17, 2010. The company will discuss with the FDA clinical development and regulatory plans for BEMA Granisetron, which is anticipated to enter Phase 1 studies in the second quarter of 2010.

13 Jan 2010

FDA approves minimally invasive procedure for treating benign and malignant tumors

A minimally invasive surgical approach developed by head and neck surgeons at the University of Pennsylvania School of Medicine has been cleared by the U.S. Food and Drug Administration (FDA). The

5 Jan 2010

Talampanel slows progression of amyotrophic lateral sclerosis

A drug already used to treat symptoms of epilepsy has potential to slow the muscle weakening that comes with amyotrophic lateral sclerosis (ALS), scientists report after completing a Phase II clinical trial-an early, small-scale test to show if the drug works and continues to be safe.

5 Jan 2010

FDA approves generic donepezil hydrochloride orally disintegrating tablets

The U.S. Food and Drug Administration approved the first generic versions of Aricept (donepezil hydrochloride) orally disintegrating tablets on Dec. 11. Donepezil hydrochloride is indicated for the treatment of dementia related to Alzheimer's disease.

5 Jan 2010

CSC completes a Series B financing round

California Stem Cell, Inc. (CSC), a leading stem cell company, announced that it has completed a Series B financing round with private investors. The financing will enable the company to support the advancement of its therapeutic products to human clinical trials, as well as the generation and distribution of its tools to aid in stem cell research and drug discovery.

21 Dec 2009

Headache on rare occasions can be a warning sign of potentially serious disorder

Headaches are extremely common. Almost everyone has experienced a severe headache at least once in his or her lifetime. In most cases, headaches are minor nuisances that resolve within a short time. However, a headache can on rare occasions be the warning sign of a potentially serious disorder that requires immediate medical attention.

19 Dec 2009

CSC's stem cell-derived motor neuron product for SMA receives FDA orphan drug designation

California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that the FDA has granted orphan drug designation to MOTORGRAFT™, a stem cell-derived motor neuron product, for the treatment of Spinal Muscular Atrophy (SMA).

9 Dec 2009

New breakthrough study shows reconstruction of human mandible bone with dental stem cells

In a statement today, StemSave(TM), Inc., the market leader in the field of stem cell recovery and cryo-preservation lauds research published in the November issue of the European Cells and Materials Journal citing the reconstruction of the human mandible bone with autologous dental pulp stem cells.

9 Dec 2009

Study reveals that majority of all vaccine preventable deaths occur in those 65 and older

Ninety percent of all vaccine preventable deaths occur in those 65 and older, including residents in nursing homes, according to highlighted studies in the Pennsylvania Patient Safety Authority's 2009 December Patient Safety Advisory.

4 Dec 2009

New study sheds light on feeding challenges faced by premature infants

A recent study conducted by researchers and physicians at Nationwide Children's Hospital sheds new light on feeding challenges often faced by premature infants. Although the prevalence of this disorder is well recognized, the feeding milestones for infants have not been well described.

3 Dec 2009

Roche ships additional quantities of Tamiflu oral suspension

Roche announced today that it has begun shipping additional quantities of Tamiflu® (oseltamivir phosphate) oral suspension (liquid).

3 Dec 2009

ImThera Medical implants its aura6000 neurostimulation device in two OSA patients

ImThera Medical, Inc. today announced that two patients have been surgically implanted with ImThera’s aura6000™ neurostimulation device for treating tongue-based Obstructive Sleep Apnea (OSA). Patients are being enrolled in ImThera’s pilot clinical investigation in Belgium with the first results expected to be published in the first half of 2010.

2 Dec 2009

Presentations at Tuesday's RSNA conference

A new study from Cincinnati Children's Hospital Medical Center reports that beverage can stay-tabs pose a potential ingestion risk. In the 1970s, U.S. manufacturers switched to the stay-tab design after safety concerns about pull-tabs. The new study found 19 cases of stay-tab ingestion at a single institution, mainly among teenagers.

30 Nov 2009

New study reveals current beverage can pull-tabs are still unsafe

Three decades ago, a study revealed that beverage can pull-tabs were being swallowed by children, prompting a switch by U.S. manufacturers to stay-tabs. But a study presented today at the annual meeting of the Radiological Society of North America (RSNA) found that the new tabs are still potentially unsafe.

30 Nov 2009

Combination therapy improves survival rates of patients with head and neck cancer

Cancer Research UK scientists have found that a combination of chemotherapy and radiotherapy improves survival from advanced head and neck cancer in patients who are not able to have surgery.

23 Nov 2009

America's Got Talent Donald Braswell to participate in "Songs for Sara" Benefit Concert

Donald Braswell, 4th place winner from TV's "America's Got Talent" 2008 season, and William Stokking, retired principal cellist of the Philadelphia Orchestra, are featured in the "Songs for Sara" Benefit Concert for Sara Ann Kronrot, a six-year-old Collingswood girl with profound cerebral palsy.

21 Nov 2009

Swallowing News and Research

Hypnosis has potential therapeutic value in children with respiratory disorders

New review highlights risks and benefits of fluoride toothpaste in young children

Parents advised to use fluoridated toothpaste to prevent tooth decay in their children

Organization of the brain's dictionary

BDSI to discuss planned BEMA Granisetron IND with the FDA

FDA approves minimally invasive procedure for treating benign and malignant tumors

Talampanel slows progression of amyotrophic lateral sclerosis

FDA approves generic donepezil hydrochloride orally disintegrating tablets

CSC completes a Series B financing round

Headache on rare occasions can be a warning sign of potentially serious disorder

CSC's stem cell-derived motor neuron product for SMA receives FDA orphan drug designation

New breakthrough study shows reconstruction of human mandible bone with dental stem cells

Study reveals that majority of all vaccine preventable deaths occur in those 65 and older

New study sheds light on feeding challenges faced by premature infants

Roche ships additional quantities of Tamiflu oral suspension

ImThera Medical implants its aura6000 neurostimulation device in two OSA patients

Presentations at Tuesday's RSNA conference

New study reveals current beverage can pull-tabs are still unsafe

Combination therapy improves survival rates of patients with head and neck cancer

America's Got Talent Donald Braswell to participate in "Songs for Sara" Benefit Concert

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News